Google
PRPO 株価分析 — PRECIPIO INC (Healthcare >> Diagnostics & Research)
PRPO に関するよくある質問
PRPOのPER（株価収益率）は？
PRECIPIO INC（PRPO）は現在PER 63.12倍で取引されています。
PRPOのROE（自己資本利益率）は？
PRECIPIO INCのROEは-6.51%です。
PRPOの配当利回りは？
PRECIPIO INCの配当利回りは0.00%です。
PRPOの品質スコア（Quality Score）は？
当社のAIはPRPOの総合財務品質を100点中23点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
PRPOは今が買い時ですか？
当社AIのタイミングスコアは100点中26点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
PRPOはどのセクターに属しますか？
PRECIPIO INCはHealthcare >> Diagnostics & Researchセクターに分類されます（NASDAQ市場）
PRPO AI Analysis Summary
Our AI summary for PRPO: PRECIPIO INC (NASDAQ), Healthcare >> Diagnostics & Research sector. The stock currently trades at a P/E of 63.12, ROE of -6.51%, a dividend yield of 0.00%. Its financial Quality Score stands at 23/100 — fundamentals below the market average. The AI Timing Score is 26/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 21.65
Price
0.46
(2.17%)
Day Change
|
|
|---|
PRPO, ファンダメンタルスコアはnot good ( ファンダメンタル = 23) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
P/Eが高い。割高銘柄。
ROEが低い
ROAが低い
ROEの伸びが低い
平均ROEが低い
ROEが昨年度比で低い
ROAがROEに比べて低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Deepscope 分析 |
|
41% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 91 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 21.65 |
| PBV / Sector |
2.67 / -29.69
|
| Earning Per Share | -0.53 |
| PE / Sector |
63.12 / 48.18
|
| PEG or PE/Growth / Sector |
-1.02 / 1.64
|
| Average 1M Daily Value |
2.69 M
GREAT
|
| Average 1W Daily Value |
2.48 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
45% |
| ポイントになる統計 |
|
56% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-08-01 08:00:21 |
| Symbol | PRPO |
| Name | PRECIPIO INC |
| Sector | Healthcare >> Diagnostics & Research |
| Market | NASDAQ |
| Listed Shares | 1.79 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 37.87 / 38,081.42 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 4 Science Park, New Haven, CT, United States, 06511
Phone: 203 787 7888
Website: https://www.precipiodx.com
Employees: 61
Description: Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a suite of robust genetic diagnostic panels; and IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Diagnostics & Research
Click a bubble to view stock details · Bubble size represents market capitalization share
